DK1015002T3 - Metal-stoffer, blandede eller sulfaterede, som fosfatbindere - Google Patents

Metal-stoffer, blandede eller sulfaterede, som fosfatbindere

Info

Publication number
DK1015002T3
DK1015002T3 DK98944055T DK98944055T DK1015002T3 DK 1015002 T3 DK1015002 T3 DK 1015002T3 DK 98944055 T DK98944055 T DK 98944055T DK 98944055 T DK98944055 T DK 98944055T DK 1015002 T3 DK1015002 T3 DK 1015002T3
Authority
DK
Denmark
Prior art keywords
mixed
sulfated
phosphate
weight
phosphate binders
Prior art date
Application number
DK98944055T
Other languages
Danish (da)
English (en)
Inventor
Maurice Webb
Norman Bryson Roberts
Benjamin Joseph Rankin
Original Assignee
Ineos Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ineos Healthcare Ltd filed Critical Ineos Healthcare Ltd
Application granted granted Critical
Publication of DK1015002T3 publication Critical patent/DK1015002T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/18—Carbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F5/00—Compounds of magnesium
    • C01F5/24—Magnesium carbonates
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00—Compounds of iron
    • C01G49/009—Compounds containing, besides iron, two or more other elements, with the exception of oxygen or hydrogen
DK98944055T 1997-09-19 1998-09-18 Metal-stoffer, blandede eller sulfaterede, som fosfatbindere DK1015002T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720061.2A GB9720061D0 (en) 1997-09-19 1997-09-19 Metal compounds as phosphate binders

Publications (1)

Publication Number Publication Date
DK1015002T3 true DK1015002T3 (da) 2006-11-13

Family

ID=10819414

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06013811.2T DK1759704T3 (da) 1997-09-19 1998-09-18 Metalforbindelser, blandede eller sulphaterede, som phosphatbindere
DK98944055T DK1015002T3 (da) 1997-09-19 1998-09-18 Metal-stoffer, blandede eller sulfaterede, som fosfatbindere

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06013811.2T DK1759704T3 (da) 1997-09-19 1998-09-18 Metalforbindelser, blandede eller sulphaterede, som phosphatbindere

Country Status (20)

Country Link
US (4) US6926912B1 (fr)
EP (2) EP1759704B1 (fr)
JP (3) JP4149659B2 (fr)
KR (2) KR100997504B1 (fr)
CN (2) CN1911245B (fr)
AT (2) ATE489958T1 (fr)
AU (1) AU9173398A (fr)
BR (1) BR9812223A (fr)
CA (1) CA2303820C (fr)
CY (2) CY1106174T1 (fr)
DE (2) DE69835217T2 (fr)
DK (2) DK1759704T3 (fr)
ES (2) ES2355925T3 (fr)
GB (1) GB9720061D0 (fr)
HK (1) HK1098390A1 (fr)
HU (2) HU227666B1 (fr)
NZ (1) NZ503136A (fr)
PL (1) PL194211B1 (fr)
PT (2) PT1015002E (fr)
WO (1) WO1999015189A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
DE19917705C1 (de) * 1999-04-20 2000-12-28 Vitasyn Gmbh Mittel zur Therapie von Hyperphosphatämie
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
CN100526219C (zh) * 2002-08-14 2009-08-12 爱尔达纳米公司 稀土金属化合物、其制造方法及其使用方法
EP2194028B1 (fr) * 2002-08-14 2022-01-26 Unicycive Therapeutics, Inc. Composés de métaux de terres rares, procédés de fabrication et leurs procédés d'utilisation
DK1660104T3 (da) * 2003-08-26 2010-06-21 Shire Holdings Ag Farmaceutisk formulering indeholdende lanthanforbindelser
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
KR101072196B1 (ko) * 2004-07-27 2011-10-10 샤이어 파마세우티컬, 인크. 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
JP2008526771A (ja) * 2004-12-30 2008-07-24 ジェンザイム コーポレーション 高リン酸血症のための亜鉛含有処置
GB0502787D0 (en) * 2005-02-10 2005-03-16 Ineos Silicas Ltd Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
WO2006134828A1 (fr) * 2005-06-09 2006-12-21 Tomotaka Yanagita Adsorbant anionique, agent de purification de l'eau ou du sol, et leur procede de fabrication
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
WO2007056405A2 (fr) * 2005-11-08 2007-05-18 Genzyme Corporation POLYMERES CONTENANT DU MAGNESIUM POUR l'HYPERPHOSPHATEMIE
AU2016213745B2 (en) * 2006-01-31 2019-03-14 Cytochroma Development Inc. Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0601899D0 (en) * 2006-01-31 2006-03-08 Ineos Silicas Ltd Compositions
JP3989525B1 (ja) * 2006-06-29 2007-10-10 ジェイファーマ株式会社 リン障害予防改善治療剤及びその製造方法
JP2009542653A (ja) * 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
EP1932807A1 (fr) * 2006-12-14 2008-06-18 Novartis AG Composés inorganiques
SI2319804T1 (sl) 2006-12-14 2015-01-30 Novartis Ag Fosfatni adsorbent na osnovi Ĺľelezo(III)-ogljikovega hidrata
JP4513819B2 (ja) 2007-03-19 2010-07-28 株式会社日立製作所 映像変換装置、映像表示装置、映像変換方法
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
NZ594730A (en) * 2009-03-02 2013-06-28 Vifor Int Ag Phosphate adsorbent comprising calcium, magnesium and iron salts for the treatment of chronic kidney deficiency and/or haemodialysis patients
US8247000B2 (en) 2009-04-10 2012-08-21 Cypress Pharmaceutical, Inc. Phosphate-binding magnesium salts and uses thereof
AU2009344184B2 (en) * 2009-04-10 2016-05-12 Cypress Pharmaceuticals, Inc. Phosphate-binding magnesium salts and uses thereof
JP5336932B2 (ja) * 2009-05-29 2013-11-06 株式会社東芝 水質浄化材料、水質浄化方法、リン酸肥料前駆体及びリン酸肥料前駆体の製造方法
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
DE102009045899B4 (de) * 2009-10-21 2012-03-22 Freie Universität Berlin Bismuthaltige Zusammensetzung zur Reduzierung der Phosphatkonzentration in Flüssigkeiten
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
US8961917B2 (en) 2010-05-12 2015-02-24 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
DE102011112898A1 (de) 2011-09-08 2013-03-14 Charité - Universitätsmedizin Berlin Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen
US9394318B2 (en) 2012-11-30 2016-07-19 Cypress Pharmaceuticals, Inc. Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
WO2020084349A1 (fr) 2018-10-25 2020-04-30 Opko Ireland Global Holdings, Ltd Procédés de traitement avec des composés métalliques mixtes
CN112816575A (zh) * 2020-12-29 2021-05-18 平光制药股份有限公司 一种碳酸司维拉姆的磷酸盐结合力的分析方法
CN115024495B (zh) * 2022-06-27 2024-03-22 北京金康普食品科技有限公司 改善肾病患者钙磷代谢的营养组合物及其应用

Family Cites Families (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2222924A (en) * 1936-12-10 1940-11-26 Degussa Preparation of cerium sulphate
US2812344A (en) * 1956-02-13 1957-11-05 Ortho Pharma Corp Ferrous calcium citrate complex
FR1214473A (fr) * 1959-01-07 1960-04-08 Procédé de préparation d'un catalyseur à base d'hydroxyde de cérium
BE590192A (fr) 1959-04-27
US3395211A (en) * 1965-12-10 1968-07-30 Carter Wallace Tableting process
US3539306A (en) * 1966-07-25 1970-11-10 Kyowa Chem Ind Co Ltd Process for the preparation of hydrotalcite
US3796792A (en) * 1969-12-12 1974-03-12 Kyowa Chem Ind Co Ltd Composite metal hydroxides
SU414849A1 (ru) * 1971-05-21 1977-09-05 Харьковский домостроительный комбинат Бетонна смесь
BE792032A (fr) 1971-12-23 1973-03-16 Baxter Laboratories Inc Dispositif de transfert de masse ayant une membrame semi-permeable disposee en spirale et presentant un faible volume de fluide
NL174720C (nl) * 1973-12-13 1984-08-01 Philips Nv Beeldweergeefcel en methode voor de vervaardiging van een vloeibaar kristallijn p-n.butyl-p'-alkoxyazobenzeen.
JPS5417518Y2 (fr) 1975-06-05 1979-07-05
PL110490B1 (en) 1976-05-19 1980-07-31 Politechnika Poznanska Agent for preparing hydrophobic solutions extracting ions of non ferrous metals from aqueous solutions also a method of producing an agent for preparing hydrophobic solutions extracting ions of non ferrous metals
DE2642984C3 (de) 1976-09-24 1980-01-24 Maschinenfabrik Karl Brieden & Co, 4630 Bochum Blasversatzleitung mit stirnseitigem Austrag
FR2435442A1 (fr) 1978-09-07 1980-04-04 Om Lab Sa Silicate de magnesium et d'aluminium synthetique, procede de fabrication de celui-ci et compositions pharmaceutiques comprenant celui-ci
US4192900A (en) 1978-10-12 1980-03-11 Merck & Co., Inc. Texturized starch products
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE3039997A1 (de) * 1980-10-23 1982-06-03 Bayer Ag, 5090 Leverkusen Phosphonohydroxyacetonitril, ein verfahren zu seiner herstellung und seine verwendung als zwischenprodukt fuer die herstellung von arzneimitteln
US4351814A (en) * 1980-12-18 1982-09-28 Kyowa Chemical Industry Co., Ltd. Hydrotalcites having a hexagonal needle-like crystal structure and process for production thereof
JPS57156419A (en) * 1981-03-24 1982-09-27 Kyowa Chem Ind Co Ltd Remedy for sideropenia
US4514389A (en) * 1981-05-06 1985-04-30 Kyowa Chemical Industry Co. Ltd. Gastric antacid and method for controlling pH of gastric juice
CA1198674A (fr) 1981-11-23 1985-12-31 Rorer International (Holdings) Inc. Compositions anti-acides
US4458026A (en) * 1982-06-02 1984-07-03 Union Carbide Corporation Catalysts for aldol condensations
US4582705A (en) * 1982-07-12 1986-04-15 Leonard Primes Composition for detoxification
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
JPS606619A (ja) 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
GB8317595D0 (en) 1983-06-29 1983-08-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4609543A (en) * 1983-11-14 1986-09-02 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS60131604A (ja) * 1983-12-20 1985-07-13 Victor Co Of Japan Ltd 磁気記録再生素子
DE3346943A1 (de) 1983-12-24 1985-07-04 Bayer Ag, 5090 Leverkusen Herstellung von hydrotalcit mit verbesserten eigenschaften
DE3402878A1 (de) * 1984-01-27 1985-08-01 Algina AG, Zug Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel
FR2559755A1 (fr) * 1984-02-20 1985-08-23 Rhone Poulenc Spec Chim Oxyde cerique a nouvelles caracteristiques morphologiques et son procede d'obtention
JPS6136222A (ja) * 1984-07-26 1986-02-20 Chugai Pharmaceut Co Ltd 高リン酸血症治療剤
US4566986A (en) * 1984-08-31 1986-01-28 Waldmann John J Flocculating agents and processes for making them
DE3520108A1 (de) * 1985-06-05 1986-12-11 Varta Batterie Ag, 3000 Hannover Positive sammlerelektrode fuer akkumulatoren mit alkalischem elektrolyten
JPH06705B2 (ja) * 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US4871392A (en) 1986-05-23 1989-10-03 American Cyanamid Company Aqueous suspension concentrate compositions of pendimethalin
US4801454A (en) 1986-07-17 1989-01-31 The Proctor & Gamble Company Processes for making colored pharmaceutical compositions
DE3864932D1 (de) * 1987-06-29 1991-10-24 Rhone Poulenc Chimie Verfahren zur gewinnung eines ceriumoxids.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
US4994283A (en) * 1987-07-02 1991-02-19 The Procter & Gamble Company Iron-calcium mineral supplements with enhanced bioavailability
DE3801382A1 (de) * 1988-01-19 1989-08-03 Ebner Anlagen & Apparate Verfahren und anlage zur umwandlung von natriumsulfat in natriumhydroxid
EP0330284B1 (fr) * 1988-02-25 1994-07-27 Yamanouchi Europe B.V. Procédé de préparation d'un granulé pharmaceutique
HU201880B (en) 1988-06-21 1991-01-28 Semmelweis Orvostudomanyi Egye Process for producing pharmaceutical compositions for profilacting and treating renal diseases and for diminishing frequency of extracorporalis dialysis
GB8826333D0 (en) 1988-11-10 1988-12-14 Unilever Plc Oral compositions
GB8902581D0 (en) 1989-02-06 1989-03-22 Telephone Cables Ltd Optical fibre cable core
US5153156A (en) 1989-04-18 1992-10-06 Aristech Chemical Corporation Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone
FR2647433B1 (fr) * 1989-05-23 1991-10-31 Lafarge Coppee Da Procede de preparation par voie aqueuse de sulfate de calcium purifie
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
US5112604A (en) 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
ES2018952A6 (es) 1989-10-17 1991-05-16 Walton Sa Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
JP2918619B2 (ja) 1990-04-06 1999-07-12 花王株式会社 金属磁性粉末の製造方法及び磁気記録媒体用塗膜
JPH0414849A (ja) * 1990-05-09 1992-01-20 Shibayama Kikai Kk チャック機構における半導体ウエハの取外し方法
DE69118886D1 (de) 1990-06-08 1996-05-23 Commw Scient Ind Res Org Sorptionsmittel für ethylen
US5300302A (en) 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid
US5246899A (en) * 1991-08-16 1993-09-21 Amoco Corporation Simplified preparation of hydrotalcite-type clays
JPH05155776A (ja) * 1991-12-02 1993-06-22 Otsuka Pharmaceut Factory Inc 高リン血症治療剤
JPH05208816A (ja) * 1992-01-28 1993-08-20 Sumitomo Metal Mining Co Ltd 水酸化セリウム及び酸化セリウムの製造方法
AU5155893A (en) 1992-04-30 1993-11-29 J.M. Huber Corporation Method for production of synthetic hydrotalcite
US5380542A (en) 1992-06-19 1995-01-10 Rhone-Poulenc Specialties Chemical Co. Dietary fiber compositions for use in foods
US5273767A (en) 1992-09-09 1993-12-28 Merck & Co., Inc. Rapidly hydrating gums
AU5589594A (en) 1992-10-29 1994-05-24 C-P Technology Limited Partnership Mixtures or complexes containing calcium and sulfate
NL9201907A (nl) * 1992-11-02 1994-06-01 Tno Peristaltisch mengende reactor en peristaltische kleppenpomp.
DE4239442C2 (de) * 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
CA2110313C (fr) * 1992-12-01 2004-10-26 Edward John Roche Compositions pharmaceutiques contenant un compose de guanidothiazole et antiacides
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
TW397686B (en) 1993-08-11 2000-07-11 Takeda Chemical Industries Ltd Antacid compositions and pharmaceutical compositions
WO1995011033A1 (fr) 1993-10-22 1995-04-27 Commonwealth Scientific And Industrial Research Organisation Polyoxometallates utilises dans le traitement des infections associees au flavivirus
TW390813B (en) 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US5976506A (en) 1994-09-21 1999-11-02 Chesebrough-Pond's Usa Co. Oral compositions
GB9506126D0 (en) 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
EP1672061B1 (fr) 1995-09-20 2008-09-10 University of Queensland Séquences nucléotidiques codant pour des enzymes ACC synthase de papaye
US5571336A (en) * 1995-09-29 1996-11-05 Wurzburger; Stephen R. Base solution for cleaning aluminum
DE19547356A1 (de) * 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US6093416A (en) 1996-01-25 2000-07-25 Young; Colin Leslie Stomach-action molluscicides
SE9602442D0 (sv) 1996-06-20 1996-06-20 Astra Ab Administration of pharmaceuticals
WO1998002185A1 (fr) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Materiaux moules par compression, a desagregation rapide, et leur procede de production
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
JPH1059842A (ja) 1996-08-13 1998-03-03 Lion Corp 錠剤用組成物及び打錠方法
JPH10101569A (ja) 1996-10-01 1998-04-21 Eisai Co Ltd 制酸剤
JPH10236960A (ja) 1997-02-24 1998-09-08 Lion Corp 制酸剤含有組成物
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JP3835638B2 (ja) 1997-06-13 2006-10-18 カルソニックカンセイ株式会社 自動車用空気調和装置
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6028023A (en) * 1997-10-20 2000-02-22 Bulldog Technologies U.S.A., Inc. Process for making, and use of, anionic clay materials
CA2322315C (fr) * 1998-03-06 2008-09-16 Eurand International S.P.A. Comprime a desintegration rapide
JPH11335269A (ja) * 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
KR100414849B1 (ko) * 1998-07-10 2004-01-13 모토로라 인코포레이티드 선택 호출 수신기를 사용하여 데모그래피 정보를 제공하고, 쿠폰을 환매하며, 어피니티 카드를 에뮬레이트 하기 위한 무선 통신 시스템의 방법 및 장치
US6171678B1 (en) * 1998-07-14 2001-01-09 Bayer Antwerp N.V. Polyurethane carpet backings with improved tuft bind
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
US6448323B1 (en) * 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
US6177581B1 (en) * 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
DE19958007A1 (de) 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
AU784593B2 (en) 2000-01-06 2006-05-11 Marantech Holding, Llc Compositions and methods for facilitating skin growth and managing skin conditions
AUPQ533700A0 (en) * 2000-01-28 2000-02-17 Commonwealth Scientific And Industrial Research Organisation Soil treatment method
US20030185886A1 (en) * 2000-05-26 2003-10-02 Hanmi Pharm. Co., Ltd. Process for the preparation of rapidly disintegrating tablet
FR2809407B1 (fr) 2000-05-26 2002-08-30 Rhodia Chimie Sa Utilisation d'hydrotalcite comme charge dans des compositions de polymeres
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
IN192168B (fr) 2000-11-24 2004-03-06 Council Scient Ind Res
CA2342007C (fr) * 2001-03-26 2009-10-20 University Technologies International, Inc. Determination des teneurs en huile et en eau d'emulsions eau/huile a l'aide de la relaxometrie rmn a faible champ
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
AU2002346065A1 (en) * 2001-07-05 2003-01-21 Marantech Holding, Llc Methods of using electron active compounds for managing conditions afflicting mammals
UA80682C2 (en) 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
AU2002318630B2 (en) * 2001-08-27 2007-05-17 Kyowa Chemical Industry Co., Ltd. Antacid and laxative tablets
AR036354A1 (es) 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
EP1430888A1 (fr) 2001-09-28 2004-06-23 Sanwa Kagaku Kenkyusho Co., Ltd. Double comprime a desintegration rapide
GB0204771D0 (en) 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
DE60212464T2 (de) 2002-04-29 2007-01-11 EGIS Gyógyszergyár Rt. Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
US20040161474A1 (en) 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
EP1551882B1 (fr) 2002-06-25 2016-05-11 Solvay USA Inc. Reduction du poids moleculaire de polysaccharides par des faisceaux d'electrons
CN1326612C (zh) 2002-08-09 2007-07-18 阿尔伯麦尔荷兰有限公司 使用含铁层状材料的费－托法
JP4348426B2 (ja) 2002-08-29 2009-10-21 独立行政法人産業技術総合研究所 高選択性脱リン剤及びその製造方法
WO2005014160A1 (fr) 2003-01-28 2005-02-17 The University Of Wyoming Research Corporation D/B/A Western Research Institute Systemes d'epuration des agents biologiques de l'air
AR045068A1 (es) 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
DK1660104T3 (da) 2003-08-26 2010-06-21 Shire Holdings Ag Farmaceutisk formulering indeholdende lanthanforbindelser
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
WO2005027876A1 (fr) 2003-08-28 2005-03-31 Ranbaxy Laboratories Limited Compositions pharmaceutiques de benzimidazole et leurs procedes de preparation
US20050260271A1 (en) * 2004-05-20 2005-11-24 Eastman Kodak Company Composition comprising layered host material with intercalated functional-active organic compound
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060177415A1 (en) 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
GB0502787D0 (en) * 2005-02-10 2005-03-16 Ineos Silicas Ltd Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
JP4823547B2 (ja) 2005-03-28 2011-11-24 株式会社ジーシー ペースト状歯科用アルギン酸塩印象材組成物
SG184754A1 (en) 2005-12-28 2012-10-30 Takeda Pharmaceutical Controlled release solid preparation
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
PL2034958T3 (pl) 2006-05-19 2010-04-30 Norbrook Lab Ltd Stabilna, wodna zawiesina o przyjemnym smaku
EP1932808A1 (fr) 2006-12-14 2008-06-18 Novartis AG Adsorbant de phosphate à base d'iron(III)-glucides
SI2319804T1 (sl) 2006-12-14 2015-01-30 Novartis Ag Fosfatni adsorbent na osnovi Ĺľelezo(III)-ogljikovega hidrata
EP1946750A1 (fr) 2007-01-18 2008-07-23 The Jordanian Pharmaceutical Manufacturing Co. Co-précipité, procédé de préparation de celui-ci et utilisations de celui-ci
WO2008129034A1 (fr) 2007-04-20 2008-10-30 Euro Support Catalyst Group Bv Composition à base d'hydroxyde double lamellaire (hdl) de type hydrotalcite et son procédé de fabrication
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Also Published As

Publication number Publication date
BR9812223A (pt) 2000-07-18
CN1268347C (zh) 2006-08-09
KR20070017241A (ko) 2007-02-08
KR100823565B1 (ko) 2008-04-21
EP1759704B1 (fr) 2010-12-01
CY1111199T1 (el) 2015-06-11
HUP0900652A2 (en) 2001-04-28
PT1759704E (pt) 2011-01-24
JP2001517633A (ja) 2001-10-09
CY1106174T1 (el) 2011-06-08
CN1911245B (zh) 2012-04-04
EP1759704A3 (fr) 2007-08-15
EP1759704A2 (fr) 2007-03-07
ATE332699T1 (de) 2006-08-15
HUP0004527A2 (hu) 2001-04-28
KR20010030624A (ko) 2001-04-16
JP4149659B2 (ja) 2008-09-10
US9242869B2 (en) 2016-01-26
DE69842028D1 (de) 2011-01-13
US7799351B2 (en) 2010-09-21
US6926912B1 (en) 2005-08-09
DK1759704T3 (da) 2011-01-24
JP2007176955A (ja) 2007-07-12
PL194211B1 (pl) 2007-05-31
US8568792B2 (en) 2013-10-29
DE69835217T2 (de) 2007-06-14
EP1015002B1 (fr) 2006-07-12
DE69835217D1 (de) 2006-08-24
ATE489958T1 (de) 2010-12-15
EP1015002A1 (fr) 2000-07-05
CA2303820C (fr) 2010-06-15
JP2008069173A (ja) 2008-03-27
KR100997504B1 (ko) 2010-12-01
CN1270526A (zh) 2000-10-18
JP4929426B2 (ja) 2012-05-09
WO1999015189A1 (fr) 1999-04-01
CN1911245A (zh) 2007-02-14
ES2355925T3 (es) 2011-04-01
HU230611B1 (hu) 2017-03-28
US20140120180A1 (en) 2014-05-01
HK1098390A1 (en) 2007-07-20
HU0900652D0 (en) 2009-12-28
AU9173398A (en) 1999-04-12
ES2268788T3 (es) 2007-03-16
US20040105896A1 (en) 2004-06-03
PT1015002E (pt) 2006-10-31
HU227666B1 (en) 2011-11-28
HUP0004527A3 (en) 2003-07-28
PL339079A1 (en) 2000-12-04
GB9720061D0 (en) 1997-11-19
US20110014301A1 (en) 2011-01-20
NZ503136A (en) 2001-04-27
CA2303820A1 (fr) 1999-04-01

Similar Documents

Publication Publication Date Title
DK1015002T3 (da) Metal-stoffer, blandede eller sulfaterede, som fosfatbindere
UA66841C2 (uk) Спосіб гідрування альфа-, омега-динітрилів та каталізатор гідрування
BR9909332A (pt) Método & produto de tratamento de água
CA2303884A1 (fr) Complexes inorganiques-polymeres utiles pour une liberation controlee de composes comprenant des composes medicinaux
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
TR200101815T2 (tr) Sulu reaktif dolgu bileşimleri (I).
EP2044938A3 (fr) Radioprotecteurs
FR2807424B1 (fr) Liant hydraulique resultant du melange d'un liant sulfatique et d'un liant comprenant le compose mineralogique c4a3s
DE69728914D1 (de) Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen
CA2259471A1 (fr) Compositions eclaircissant la peau
ATE367368T1 (de) Hydraulisches bindemittel
CA2214872A1 (fr) Composes a base de benzothiophene, compositions et methodes
FR2705562B1 (fr) Utilisation d'un composé organofluoré hydrocarboné comme liant dans des compositions cosmétiques sous forme de poudre et compositions en comportant.
RU96124643A (ru) Сырьевая смесь для получения фосфатного вяжущего
清水穣 et al. SLAVOJ ŽIŽEK: FOR THEY KNOW NOT WHAT THEY DO: Enjoyment as a political factor Verso, 1991
RU96102801A (ru) Состав для изготовления керамических материалов
RU97110768A (ru) Чугун для тормозных колодок
RU97104322A (ru) Клинкер для низкоалюминатного цемента
RU95118888A (ru) Комплексная добавка для цементных материалов
PT1157140E (pt) Utilizacao de ligas de zinco
RU95121426A (ru) Шихта для получения вольфрама
RU95119615A (ru) Вяжущее
RU93036134A (ru) Бишофит как основа для лекарственных препаратов
RU98115962A (ru) Вяжущее
RU93036098A (ru) Смесь для покрытия плит